Issue Information

2024-7-1

Sex‐related differences in pulmonary vascular volume distribution

2024-7-1

Better efficacy of sequential combination with balloon pulmonary angioplasty after long‐term riociguat for patients with inoperable chronic thromboembolic pulmonary hypertension

2024-7-1

Human pulmonary microvascular endothelial cells respond to DAMPs from injured renal tubular cells

2024-7-1

Quantifying the impact of post‐acute sequelae of coronavirus on the cardiopulmonary endurance of athletes

2024-7-1

Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH‐CTD): Real‐world experience from EXPOSURE

2024-7-1

Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot study

2024-7-1

Pulmonary perfusion in long‐term survivors of COVID‐19‐related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation

2024-7-1

Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study

2024-7-1

Clinical characteristics and anticoagulation patterns of patients with acute pulmonary thromboembolism and hemoptysis

2024-7-1

Balloon pulmonary angioplasty for proximal chronic thromboembolic pulmonary hypertension in patients ineligible for pulmonary endarterectomy

2024-7-1

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

2024-7-1

Characteristics and risk profiles of patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension living permanently at >2500 m of high altitude in Ecuador

2024-7-1

Editorial on “A systematic review of the impact of pulmonary thromboendarterectomy on health related quality of life”

2024-7-1

Pretransplant NT‐proBNP levels are associated with mortality among lung transplant recipients

2024-7-1

An adult patient with pulmonary arterial hypertension, a <i>NOTCH3</i> mutation, and leflunomide exposure

2024-7-1

Correction to “Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension”

2024-7-1

Early detection of pulmonary arterial hypertension through [¹⁸F] positron emission tomography imaging with a vascular endothelial receptor small molecule

2024-7-1

Editorial on “Characteristics and risk profiles of patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension living permanently at &gt;2500 m of high altitude in Ecuador”

2024-7-1

Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary disease

2024-7-1

Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension

2024-7-1

Scoping review of post‐TB pulmonary vascular disease: Proceedings from the 2nd International Post‐Tuberculosis Symposium

2024-7-1

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension

2024-7-1

Association of risk assessment at diagnosis with healthcare resource utilization and health‐related quality of life outcomes in pulmonary arterial hypertension

2024-7-1

Tricuspid annular plane systolic excursion in pulmonary hypertension—Moving beyond the sector plane

2024-7-1

A systematic review of the impact of pulmonary thromboendarterectomy on health‐related quality of life

2024-7-1

Creating a digital approach for promoting physical activity in pediatric pulmonary hypertension: A framework for future interventions

2024-7-1

We are all in this together: Understanding organ crosstalk in the pathogenesis of acute respiratory distress syndrome

2024-7-1

Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension

2024-7-1

Carnitine consumption and effect of oral supplementation in human pulmonary arterial hypertension: A pilot study

2024-7-1

Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension

2024-7-1

Early identification of SOX17 deficiency in infants to guide management of heritable pulmonary arterial hypertension using PDA stent to create reverse Potts shunt physiology

2024-4-1

Balloon pulmonary angioplasty under awake veno‐arterial extracorporeal membrane oxygenation in a patient with class III obesity with chronic thromboembolic pulmonary hypertension complicated with multiple serious comorbidities

2024-4-1

Cardiopulmonary exercise testing and the 2022 definition of pulmonary hypertension

2024-4-1

Early bedside detection of pulmonary perfusion defect by electrical impedance tomography after pulmonary endarterectomy

2024-4-1

Nonsurgical treatment of a patient with decompensated right ventricular failure due to chronic thromboembolic pulmonary hypertension with proximal clot location—A case report

2024-4-1

A perfectly imperfect engine: Utilizing the digital twin paradigm in pulmonary hypertension

2024-4-1

Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross‐sectional scientific survey (CLARITY)

2024-4-1

Identifying consistent echocardiographic thresholds for risk stratification in pulmonary arterial hypertension

2024-4-1

Assessing quality of life in pulmonary arterial hypertension: An independent prognostic marker

2024-4-1

Left main coronary artery compression in precapillary pulmonary hypertension

2024-4-1

Ruptured pulmonary arteriovenous fistula causing hemothorax in a patient with hereditary hemorrhagic telangiectasia: A case report

2024-4-1

Reduced exercise capacity occurs before intrinsic skeletal muscle dysfunction in experimental rat models of pulmonary hypertension

2024-4-1

2024 Annual Congress of the Pulmonary Vascular Research Institute

2024-4-1

(18)F‐fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH

2024-4-1

NF‐κB affected the serum levels of TNF‐α and IL‐1β via activation of the MAPK/NF‐κB signaling pathway in rat model of acute pulmonary microthromboembolism

2024-4-1

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy

2024-4-1

Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019)

2024-4-1